Journal article
Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial
Meningococcal conjugate vaccines protect individuals directly, but can also confer herd protection by interrupting carriage transmission. We assessed the effects of meningococcal quadrivalent glycoconjugate (MenACWY-CRM) or serogroup B (4CMenB) vaccination on meningococcal carriage rates in 18–24-year-olds.
Authors
Languages
- English
Publication year
2014
Journal
Vaccine
Volume
9960
Type
Journal article
Categories
- Service delivery
Diseases
- Meningococcal meningitis
Countries
- United Kingdom Of Great Britain And Northern Ireland
Tags
- New vaccine introduction
WHO Regions
- European Region